85 filings
Page 4 of 5
8-K
0278ygv2
16 Aug 21
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2021 Results and Provides Business Update
4:11pm
10-Q
j1n0mi6xabbjf7
13 Aug 21
Quarterly report
4:06pm
S-8
dfgyv hqy6loegepy
19 Jul 21
Registration of securities for employees
5:27pm
8-K
04jl nc7ot7sj
29 Jun 21
ACURX PHARMACEUTICALS, INC. announces pricing of $15 Million
5:00pm
424B4
7rxau
28 Jun 21
Prospectus supplement with pricing info
6:02am
EFFECT
ntm87ey 5a0e8nfwbm1
25 Jun 21
Notice of effectiveness
12:15am
CERT
jqt8vvo8srgq
24 Jun 21
Certification of approval for exchange listing
10:00am
8-A12B
l2pk2hj0flizkl2
23 Jun 21
Registration of securities on exchange
4:06pm
CORRESP
6y4vmu2dsaiiwancjp
22 Jun 21
Correspondence with SEC
12:00am
CORRESP
wixkqw4dwq8
22 Jun 21
Correspondence with SEC
12:00am
FWP
z02el94j88 ooyqc
11 Jun 21
Free writing prospectus
6:05am
S-1/A
twg2z10u8ygyw8
11 Jun 21
IPO registration (amended)
6:02am
S-1
8jdvrbtvp5gfzxoyq3j
27 May 21
IPO registration
12:00am
CORRESP
nib32t43 6b4xsci7kq
26 May 21
Correspondence with SEC
12:00am
UPLOAD
4i2dyw
21 May 21
Letter from SEC
12:00am
DRSLTR
001urvr3 35c6psjse6q
10 May 21
Correspondence regarding draft registration statement
12:00am
DRS/A
cv4mmoqb
10 May 21
Draft registration statement (amended)
12:00am
UPLOAD
2zsqg0pg6l mwzjuwu
30 Apr 21
Letter from SEC
12:00am
DRS
i7um bp646x7uv83
5 Apr 21
Draft registration statement
12:00am